(Updated with index futures, Netflix, Schlumberger, Biogen, Salesforce, T-Mobile US, Ally Financial, Chinese groups listed on Wall Street)
PARIS, January 20 (Reuters) –
Top stocks to watch on Friday on Wall Street, where futures on major indices suggest an open down from
0.03
% for the Dow Jones, while the Standard & Poor’s 500 could nibble 0.1% and the Nasdaq gain 0.46%:
* NETFLIX – Online video service co-founder Reed Hastings announced Thursday that he is stepping down as chief executive, handing helm to a duo of his deputy and the chief operating officer, following the publication of the group’s results, which show a quarterly gain in subscribers that exceeded expectations. The action climbed 6.2% in pre-market.
* ALPHABET will cut 12,000 jobs, its chief executive said in a memo to employees seen by Reuters. The action takes 1.7% before the market.
* NORDSTROM lowered its full-year profit forecast on Thursday after reporting weak sales over the Christmas period at its Rack discount stores despite deep promotions and discounts. The action fell 3.7% before the market.
* SCHLUMBERGER takes 1.5% in pre-market after a profit in the fourth quarter exceeded Wall Street expectations, driven by strong demand for services and drilling equipment.
* AMAZON on Thursday announced plans to increase the prices of some of its music subscription plans starting in February.
* T-MOBILE US – The third-largest mobile operator by number of subscribers in the United States said Thursday it was investigating a flaw in its systems involving 37 million postpaid and prepaid accounts, which could expose it to damage. significant loads. The action fell 2.4% before the market.
* INTEL – Italy is just one of many destinations likely to host Intel’s new chip factory and a decision should be made by the end of the year, the chief executive said on Friday of the group, Pat Gelsinger, to the Italian daily Corriere della Sera.
* TEXAS INSTRUMENTS announced on Thursday the departure next April of its managing director Rich Templeton and his replacement by the current deputy managing director Haviv Ilan in a difficult context for the chipmaker against a backdrop of falling demand in the sector.
* ELI LILLY announced Thursday that the Food and Drug Administration (FDA), the American health authority, had rejected an accelerated approval of its experimental treatment against Alzheimer’s disease for lack of sufficient data from clinical trials. In pre-market, the action Eli Lilly yields 1.1% while its competitor BIOGEN advances by 1.02%.
* ALLY FINANCIAL jumped 9.9% after better-than-expected adjusted operating profit and revenue in the fourth quarter.
* JPMORGAN was given the green light by Chinese authorities on Thursday to expand its business in the country, as Beijing seeks to boost foreign business confidence after the lifting of the “zero COVID” policy.
* SALESFORCE fell 1.4% in pre-market trading after Cowen’s recommendation was lowered to “performance in line with the market” against “outperformance”.
* Chinese groups listed on Wall Street ALIBABA GROUP HOLDING, JD.COM and PINDUODUO take 1.4% to 2.3% as the Lunar New Year long weekend approaches.
* RALPH LAUREN – Barclays begins tracking at “overweight”.
* REGENERON PHARMACEUTICALS – JP Morgan raises its recommendation to ‘overweight’ from ‘neutral’. (Written by Claude Chendjou, edited by Blandine Hénault)